Neuroleptic malignant syndrome: half a century of uncertainty suggests a Chimera
Pharmacoepidemiol Drug Saf
.
2010 Aug;19(8):876-7.
doi: 10.1002/pds.2008.
Author
P Ken Gillman
PMID:
20665596
DOI:
10.1002/pds.2008
No abstract available
Publication types
Comment
Letter
MeSH terms
Causality
Dopamine Antagonists / adverse effects*
Humans
Malignant Hyperthermia
Neuroleptic Malignant Syndrome* / genetics
Serotonin Syndrome
Time Factors
Substances
Dopamine Antagonists